KPT-9274, as a selective and allosteric PAK4 inhibitor, significantly inhibits the proliferation of pancreatic cancer cells with preference over normal human ductal epithelial (Aboukameel et al., 2017). The gene discussed is PAK4; the disease is pancreatic neoplasm.